Intellia Therapeutics (NTLA) Treasury Shares (2015 - 2026)

Intellia Therapeutics (NTLA) has 12 years of Treasury Shares data on file, last reported at $6.3 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 13.83% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 13.83% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, down 6.33% from the prior year.
• Treasury Shares for Q1 2026 stood at $6.3 million, up from $5.2 million in the prior quarter.
• Over the last five years, Treasury Shares for NTLA reached as high as $6.3 million in Q1 2026 and fell as low as $1.4 million in Q1 2022.
• Historically, Treasury Shares has averaged $4.3 million across 5 years, with a median of $5.2 million in 2025.
• Across the five-year window, Treasury Shares jumped 334.88% in 2022 and declined 6.33% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $1.9 million in 2022, then surged by 108.19% to $4.0 million in 2023, then surged by 37.26% to $5.5 million in 2024, then declined by 6.33% to $5.2 million in 2025, then advanced by 21.05% to $6.3 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $6.3 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.